Program directory · Correctional Service Canada
Contraband Interdiction and Management
- Department
- Correctional Service Canada
- Program code
- BUJ03 (CSC)
- Core responsibility
- Care and Custody
- In Departmental Plans
- 2018-19 – 2026-27 · New since an earlier plan
What it does
The Contraband Interdiction and Management Program contributes to Care and Custody through the development, implementation, and coordination of policies and activities designed to prevent the introduction of contraband items and/or reduce their presence within CSC facilities. This is done in recognition of the harms associated with the introduction, trafficking, financing and distribution of contraband within CSC facilities, including a focused effort on mitigation strategies for reducing the presence of contraband, and ensuring those involved are held accountable.
Key activities include the collection, analysis and sharing of intelligence related to the introduction, trafficking, financing and distribution of contraband within CSC facilities. Detecting substance use and searching for and seizing contraband items are is accomplished through intelligence activities and security measures such as urinalysis, detector dog teams, drug detection and identification tools, drone and cellphone detection/mitigation technologies, static and dynamic security practices and the imposition of risk management measures.
Source: the department's Program Inventory, via GC InfoBase.
History and lineage
First appears in GC InfoBase's actual spending by program in 2018-19. The data does not record when a program was created; it may be older than its first appearance here, which is limited by the sources (program spending starts in 2010-11, Departmental Plans in 2018-19).
| Program | Relation | Years with data | Actual spending over those years |
|---|---|---|---|
| Contraband Interdiction and Management | This program | 2018-19 – 2028-29 | $93M |
No earlier or later program in the same department has a similar name.
Significant changes in scope and budget
Detected from the data: renames between plans, programs it appears to replace, merge with or split into (matched by name), year-over-year changes in spending of at least 25% and $5M, or in employees of at least 20% and 25 FTEs, linked budget measures, and results indicators added or dropped.
| Year | What changed | Source |
|---|---|---|
| 2020-21 | Renamed from “Drug Interdiction” to “Drug Enforcement”. | GC InfoBase program names by year |
| 2026-27 | Indicators added: Percentage of contraband items seized at the point of introduction | Departmental Results Framework (GC InfoBase) |
| 2026-27 | Indicators dropped: Rate of critical drug-related incidents per 1,000 offenders in federal custody (overdose and suspected overdose offender deaths in custody) - (Objective: Zero); Rate of minor/moderate drug-related incidents per 1,000 offenders in federal custody; Rate of serious drug-related incidents per 1,000 offenders in federal custody | Departmental Results Framework (GC InfoBase) |
| 2026-27 | Renamed from “Drug Enforcement” to “Contraband Interdiction and Management”. | GC InfoBase program names by year |
Success criteria
The program's indicators from its department's Departmental Results Framework: the target set in each year's plan, and the result reported the following year. Source: GC InfoBase.
Historical: targets against results
Bars: result reported. Dashed line: target.
| Report year | Target | Due | Result | Status |
|---|---|---|---|---|
| 2018-19 | ≤ 0.24 | 2019 | 0.35 Even with CSC’s coordinated efforts to prevent use, treat dependency, and reduce the production, introduction and distribution of illicit drugs, CSC’s drug-related results are similar to trends observed in the community, particularly in relation to opioids. The opioid crisis, and the evolution of drug introduction methods, and more effective interdiction efforts may provide a partial explanation… | Not met |
| 2019-20 | ≤ 0.24 | 2020 | 0.44 CSC is working to improve results. For further information, please refer to the 2019-20 Departmental Results Report. | Not met |
| 2020-21 | ≤ 0.24 | 2021 | 0.08 | Met |
| 2021-22 | ≤ 0.42 | 2022 | 0.08 | Met |
| 2022-23 | ≤ 0.42 | 2023 | 0.38 | Met |
| 2023-24 | ≤ 0.69 | 2024 | 0.94 CSC is working to improve results. For further information, please refer to the 2023-24 Departmental Results Report. | Not met |
| 2024-25 | ≤ 0.57 | 2025 | 0.2 CSC is working to improve results. For further information, please refer to the 2024-25 Departmental Results Report. | Met |
Bars: result reported. Dashed line: target.
| Report year | Target | Due | Result | Status |
|---|---|---|---|---|
| 2018-19 | ≤ 225.2 | 2019 | 293.2 Even with CSC’s coordinated efforts to prevent use, treat dependency, and reduce the production, introduction and distribution of illicit drugs, CSC’s drug-related results are similar to trends observed in the community, particularly in relation to opioids. The opioid crisis, and the evolution of drug introduction methods, and more effective interdiction efforts may provide a partial explanation… | Not met |
| 2019-20 | ≤ 225.2 | 2020 | 342 CSC is working to improve results. For further information, please refer to the 2019-20 Departmental Results Report. | Not met |
| 2020-21 | ≤ 225.2 | 2021 | 318.8 CSC is working to improve results. For further information, please refer to the 2020-21 Departmental Results Report. | Not met |
| 2021-22 | ≤ 257.8 | 2022 | 356.5 CSC is working to improve results. For further information, please refer to the 2021-22 Departmental Results Report. | Not met |
| 2022-23 | ≤ 257.8 | 2023 | 483.9 CSC is working to improve results. For further information, please refer to the 2022-23 Departmental Results Report. | Not met |
| 2023-24 | ≤ 459.6 | 2024 | 520.3 CSC is working to improve results. For further information, please refer to the 2023-24 Departmental Results Report. | Not met |
| 2024-25 | ≤ 459.6 | 2025 | 446.1 | Met |
Bars: result reported. Dashed line: target.
| Report year | Target | Due | Result | Status |
|---|---|---|---|---|
| 2018-19 | ≤ 3.72 | 2019 | 6.57 Even with CSC’s coordinated efforts to prevent use, treat dependency, and reduce the production, introduction and distribution of illicit drugs, CSC’s drug-related results are similar to trends observed in the community, particularly in relation to opioids. The opioid crisis, and the evolution of drug introduction methods, and more effective interdiction efforts may provide a partial explanation… | Not met |
| 2019-20 | ≤ 3.72 | 2020 | 11.37 CSC is working to improve results. For further information, please refer to the 2019-20 Departmental Results Report. | Not met |
| 2020-21 | ≤ 3.72 | 2021 | 8.39 CSC is working to improve results. For further information, please refer to the 2020-21 Departmental Results Report. | Not met |
| 2021-22 | ≤ 5.2 | 2022 | 7.38 CSC is working to improve results. For further information, please refer to the 2021-22 Departmental Results Report. | Not met |
| 2022-23 | ≤ 5.2 | 2023 | 8.66 CSC is working to improve results. For further information, please refer to the 2022-23 Departmental Results Report. | Not met |
| 2023-24 | ≤ 7.22 | 2024 | 8.3 CSC is working to improve results. For further information, please refer to the 2023-24 Departmental Results Report | Not met |
| 2024-25 | ≤ 7.22 | 2025 | 3.64 | Met |
Current: the 2026-27 plan's targets
| Report year | Target | Due | Result | Status |
|---|---|---|---|---|
| 2026-27 | Target to be determined | 2027 | — | Planned |
Future goals: targets due after 2026-27
No targets with a later due date.
Spending and employees: planned against actual
Spending
Show the numbers
| Fiscal year | Planned | Actual |
|---|---|---|
| 2018-19 | $10.9M | $12.6M |
| 2019-20 | $11.6M | $12.8M |
| 2020-21 | $13.6M | $12.7M |
| 2021-22 | $12.3M | $12.3M |
| 2022-23 | $14M | $12.4M |
| 2023-24 | $12.9M | $13.9M |
| 2024-25 | $12.3M | $16.3M |
| 2025-26 | $13.1M | — |
| 2026-27 | $14.6M | — |
| 2027-28 | $14.4M* | — |
| 2028-29 | $14.3M* | — |
Employees (FTEs)
Show the numbers
| Fiscal year | Planned | Actual |
|---|---|---|
| 2018-19 | 96 | 91 |
| 2019-20 | 91 | 86 |
| 2020-21 | 90 | 91 |
| 2021-22 | 93 | 86 |
| 2022-23 | 89 | 83 |
| 2023-24 | 85 | 88 |
| 2024-25 | 90 | 93 |
| 2025-26 | 95 | — |
| 2026-27 | 90 | — |
| 2027-28 | 90* | — |
| 2028-29 | 90* | — |
Planned spending, plan by plan
Each row is one year's Departmental Plan and its forecast for the next three fiscal years; read a column down to see how the forecast for one year changed. The last row is what was actually spent. Click an amount for its source. Biggest changes in federal spending plans
| Plan | 2018-19 | 2019-20 | 2020-21 | 2021-22 | 2022-23 | 2023-24 | 2024-25 | 2025-26 | 2026-27 | 2027-28 | 2028-29 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-19 plan | $10,861,731 | $10,847,727 | $10,845,107 | ||||||||
| 2019-20 plan | $11,580,050 | $11,552,047 | $11,543,854 | ||||||||
| 2020-21 plan | $13,555,692 | $13,684,918 | $13,830,383 | ||||||||
| 2021-22 plan | $12,330,431 | $12,438,704 | $12,494,447 | ||||||||
| 2022-23 plan | $13,965,211 | $13,793,711 | $13,308,916 | ||||||||
| 2023-24 plan | $12,877,076 | $12,879,955 | $12,827,366 | ||||||||
| 2024-25 plan | $12,277,864 | $12,279,876 | $12,288,176 | ||||||||
| 2025-26 plan | $13,141,658 | $13,137,532 | $13,142,231 | ||||||||
| 2026-27 plan | $14,551,335 | $14,439,237 | $14,340,825 | ||||||||
| Actual | $12,608,824 | $12,838,934 | $12,682,078 | $12,344,699 | $12,351,966 | $13,929,687 | $16,284,926 |
Actual spending is from Departmental Results Reports and the Public Accounts, as published in GC InfoBase. FTEs are full-time equivalents.